Loading…
Unilever's Indian arm selling soaps, shampoos, packaged foods and home-care products nationwide.
Unilever's Indian arm selling soaps, shampoos, packaged foods and home-care products nationwide.
Sells everyday products in small, low-priced packs through distributors to millions of neighbourhood shops, so volume and distribution reach decide results. Unilever owns the majority, and the Indian company pays for the group's brands and technology through royalties. The 2020 merger with GSK's Indian consumer arm added Horlicks and Boost malt drinks.
In one line: India's Procter & Gamble.
Moat: wide (brand, distribution, scale). Unmatched rural/urban distribution reach and decades-old trusted brands across categories.
Headquarters: Mumbai, India · Founded: 1933 · Employees: 24,989
Size Hindustan Unilever (HINDUNILVR.NS) is an India Consumer Staples company (Household/Personal Care) with a market value of $49.6B, the 13th largest of 1,058 India companies the cockpit tracks. Shares closed at ₹1,998 on 6 Nov 2026.
Performance Over six months the shares fell 12.1%, against +19.1% for the median peer and 0.0% for the India market (cap-weighted) — lowest of 13 in its peer set.
Growth Revenue grew 6.4% over the last twelve months (peer median -1.8%); the operating margin is 20.9% (peer median 15.2%).
Valuation It trades at 41.5× forward earnings against a peer median of 23.4× (most expensive of 13).
Price implies For today's price to make sense, revenue must grow about 27% a year for seven years (Req g). Recent delivered growth is +7%, so the hurdle is +21 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 13.1 points above its cost of capital (12.7% WACC).
Next results Next results expected around 11 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹684B | ₹643B | ₹611B | ₹617B | ₹604B |
| Revenue growth | — | +5% | -1% | +2% | — |
| Gross profit | ₹291B | ₹276B | ₹266B | ₹271B | ₹241B |
| EBITDA | ₹157B | ₹152B | ₹148B | ₹147B | ₹142B |
| Net income | ₹151B | ₹150B | ₹106B | ₹103B | ₹101B |
| Free cash flow | n/a | ₹102B | ₹115B | ₹144B | ₹90.7B |
| Capital expenditure | n/a | ₹13.6B | ₹12.8B | ₹14.8B | ₹11.9B |
| Total debt | ₹16.7B | ₹14.8B | ₹16.5B | ₹14.8B | ₹12.2B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Hindustan Unilever HINDUNILVR.NS | $49.6B | -12% | +6% | 21% | 41.5× | 27.2% |
| Procter & Gamble Hygiene & Health Care PGHH.NS | $2.40B | -29% | -2% | 24% | 27.3× | 15.4% |
| ITC ITC.NS | $37.5B | -8% | -2% | 30% | 20.2× | 13.2% |
| Godrej Consumer Products GODREJCP.NS | $9.19B | -18% | +12% | 18% | 37.0× | 31.7% |
| Dabur India DABUR.NS | $7.13B | -19% | +9% | 15% | 32.1× | 27.3% |
| Nestle India NESTLEIND.NS | $26.0B | -13% | +22% | 21% | 59.4× | 36.6% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | HINDUNILVR.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +7.1% | +10.4% | 2nd lowest of 13 |
| 6-month return | -12.1% | +19.1% | lowest of 13 |
| Distance from 52-week high | -19.4% | -4.9% | 2nd lowest of 13 |
| Revenue growth (TTM) | +6.4% | -1.8% | highest of 13 |
| Operating margin | 20.9% | 15.2% | 3rd highest of 13 |
| Forward P/E | 41.5× | 23.4× | most expensive of 13 |
| Growth the price implies (Req g, 7 yrs) | 27.2% | 2.9% | most demanding of 13 |
| Growth delivered (Del g) | +6.5% | +3.0% | 3rd highest of 13 |
| Hurdle (Req g minus delivered) | +20.7 pp | +1.7 pp | 2nd most demanding of 13 |
| ROIC minus cost of capital | +13.1 pp | +6.4 pp | 3rd highest of 13 |
| EV / EBITDA | 29.4× | 15.1× | most expensive of 13 |
| Net debt / EBITDA | -0.5× | 1.6× | 2nd least indebted of 13 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Hindustan Unilever HINDUNILVR.NS | India | $49.6B | -12% | +6% | 21% | 41.5× | 27.2% | +6.5% |
| Reckitt Benckiser RKT.L | United Kingdom | $47.6B | +22% | -2% | 28% | 16.4× | 1.6% | +0.3% |
| Givaudan GIVN.SW | Switzerland | $45.8B | +47% | -2% | 18% | 34.0× | 10.6% | +3.4% |
| Estée Lauder Companies (The) EL | United States | $39.9B | +28% | +6% | 13% | 31.1× | 16.8% | -1.5% |
| Kimberly-Clark KMB | United States | $66.5B | +12% | -12% | 14% | 15.3× | 4.1% | -3.0% |
| Colgate-Palmolive CL | United States | $76.8B | +10% | +6% | 22% | 24.2× | -5.5% | +4.4% |
| DSM-Firmenich DSFIR.AS | Netherlands | $29.5B | +62% | -45% | 8% | 30.1× | 24.3% | +2.5% |
| Church & Dwight CHD | United States | $25.8B | +17% | +2% | 18% | 27.4× | 6.9% | +4.8% |
| Kao 4452.T | Japan | $21.8B | +33% | +6% | 10% | 24.4× | 1.5% | +4.1% |
| Beiersdorf BEI.DE | Germany | $20.4B | +21% | -2% | 12% | 22.6× | -2.3% | +7.0% |
| Essity ESSITY-A.ST | Sweden | $19.9B | +17% | -2% | 12% | 15.4× | -3.3% | +2.6% |
| Unilever ULVR.L | United Kingdom | $143B | +15% | -20% | 20% | 18.4× | 8.0% | -0.8% |
| Puig Brands PUIG.MC | Spain | $12.5B | +16% | +4% | 16% | 17.9× | -3.0% | +11.7% |